Is amniotic fluid analysis the key to preterm labor? A model using interleukin-6 for predicting rapid delivery - 09/09/11
Abstract |
OBJECTIVE: Our purpose was to create a model for predicting amnionitis and rapid delivery in preterm labor patients by use of amniotic fluid interleukin-6 and clinical parameters.
STUDY DESIGN: Amniotic fluid was cultured and analyzed, and a clinical score (incorporating gestational age, amniotic fluid Gram stain, glucose, leukocyte esterase, and maternal serum C-reactive protein) was determined in 111 patients diagnosed with preterm labor. Statistical analysis involved t tests, χ2, logarithmic regression, and multivariate regression analysis (P ≤ .05).
RESULTS: The incidence of positive amniotic fluid cultures was 8.7% (9 of 103 patients). Patients with positive cultures of the amniotic fluid had a shorter delivery interval (4.8 ± 7.5 vs 28.9 ± 25.4 days, P < .001). Patients with elevated amniotic fluid interleukin-6 (≥7586 pg/ml) were more likely to have a positive amniotic fluid culture (relative risk = 8.8, 95% confidence interval = 1.6 to 47.4, P < .001) and to be delivered within 2 days (relative risk = 16.8, 95% confidence interval = 4.5 to 62.7, P < .001). Stepwise multivariate regression analysis yielded a model using interleukin-6, cervical dilatation, and gestational age (r 2 = 0.63, P < .001) with a specificity of 100% for predicting delivery within 2 days of amniocentesis.
CONCLUSIONS: A mathematical model using maternal amniotic fluid interleukin-6 seems to be a useful clinical tool for quantifying the interval to preterm birth for patients in preterm labor. (Am J Obstet Gynecol 1998;179:172-8.)
Le texte complet de cet article est disponible en PDF.Keywords : Preterm labor, amniotic fluid analysis, interleukin-6
Plan
 | From the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology,a and the Division of Biostatistics, Department of Mathematics,b University of New Mexico Health Sciences Center. |
| Supported in part by Pfizer-Roerig, Inc, grant No. NCRR-GCRC M01-RR00997, and National Institutes of Health grant No. 5T35HD074603. |
 | Reprints not available from the authors. |
| 0002-9378/98 $5.00 + 0 6/1/87728 |
Vol 179 - N° 1
P. 172-178 - juillet 1998 Retour au numéro
Article précédent
- Rehospitalizations and outpatient contacts of mothers and neonates after hospital discharge after vaginal delivery
- Susan F. Meikle, Ella Lyons, Peter Hulac, Miriam Orleans
- Which cutoff level should be used in screening for glucose intolerance in pregnancy?
- Matteo Bonomo, Maria Luisa Gandini, Arturo Mastropasqua, Cristina Begher, Umberto Valentini, David Faden, Alberto Morabito, For the Definition of Screening Methods for Gestational Diabetes Study Group of the Lombardy Section of the Italian Society of Diabetology
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?